OSO BioPharmaceuticals Streamlines Processes and Cuts Costs Using TrackWise(R) Enterprise...
* Reuters is not responsible for the content in this press release.
OSO BioPharmaceuticals Streamlines Processes and Cuts Costs Using TrackWise(R)
Enterprise Quality Management Solution
Total Solution Delivers Enterprise Quality Management with Fully Integrated
Document Management Capabilities
HOLMDEL, N.J., Aug. 17 /PRNewswire/ -- Sparta Systems, Inc., the maker of
TrackWise software and the market leader in enterprise quality and compliance
solutions, today announced that OSO BioPharmaceuticals Manufacturing, LLC
(OsoBio) has deployed the TrackWise Enterprise Quality Management Solution
(EQMS) to address a wide range of quality system and electronic document
management system (EDMS) needs. Companies like OsoBio benefit from greater
control, stricter oversight and streamlined processes across enterprise-wide
quality management and regulatory compliance activities by effectively
integrating their document management seamlessly into their quality system.
"As a new, standalone contract manufacturing organization, we understand that
streamlined, efficient processes are key to our success and profitability,"
said Brian Board, director of quality systems at OsoBio, a leading provider of
sterile contract manufacturing and drug development services. "Since using
the TrackWise Document Management solution, OsoBio has been able to save close
to $2 million by enabling and optimizing enterprise-wide collaboration and
regulatory compliance activities, giving us a competitive edge in the
marketplace."
This best-of-breed solution extends the TrackWise EQMS with technology powered
by the proven EMC Documentum platform to deliver a truly integrated solution.
Unlike other "one-size-fits-all" modular quality systems vendors, Sparta
Systems has followed the focused approach of providing a best-of-breed
document management platform that meets the stringent requirements of the
multiple market tiers within regulated industries through a seamless and
familiar user experience.
"Organizations are rapidly realizing reduced risk and finding operational
efficiencies as they not only consolidate their broad quality systems into a
single solution, but also converge document management processes at the same
time," said Mike Jovanis, vice president, product management at Sparta
Systems. "We are happy to have worked with OsoBio to achieve such a
substantial cost savings as they consolidated a broad range of needs into
their TrackWise EQMS."
For more information on the TrackWise Document Management solution, please
contact info@spartasystems.com.
About Sparta Systems
Sparta Systems, Inc. is an industry leader for global quality and compliance
management systems. Its TrackWise product is a Web-based software application
used by quality, manufacturing and regulatory affairs professionals to manage
quality and compliance issues across the enterprise. The company has more
than 14 years of experience and an extensive customer base in the life
sciences and other highly regulated industries. Sparta Systems offers its
customers a complete solution for global quality management needs, including
the onsite support required throughout the project lifecycle. More
information about Sparta Systems and TrackWise can be found at
www.spartasystems.com.
Sparta Systems, the Sparta Systems logo, and TrackWise are trademarks or
registered trademarks of Sparta Systems, Inc. Other marks are trademarks or
registered trademarks of their respective owners.
PR Contacts:
Jon Rabinowitz
Director of Marketing
Sparta Systems, Inc.
Tel: 732.203.0400, ext. 121
jon.rabinowitz@spartasystems.com
Katy Zack
Articulate Communications Inc.
Tel: 212.255.0080, ext. 11
kzack@articulatepr.com
SOURCE Sparta Systems, Inc.
Jon Rabinowitz, Director of Marketing of Sparta Systems, Inc.,
+1-732-203-0400, ext. 121, jon.rabinowitz@spartasystems.com; or Katy Zack of
Articulate Communications Inc., +1-212-255-0080, ext. 11,
kzack@articulatepr.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters